BA
NEOS

BlackRock Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History

BlackRock Advisors’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$23K Hold
3,896
– – ﹤0.01% 3433
2016
Q3 		$26K Hold
3,896
– – ﹤0.01% 3397
2016
Q2 		$36K Buy
3,896
+2,089
+116% +$19.9K ﹤0.01% 3313
2016
Q1 		$19K Buy
1,807
+642
+55% +$6.77K ﹤0.01% 3443
2015
Q4 		$17K Sell
1,165
-1,010
-46% -$15.2K ﹤0.01% 3536
2015
Q3 		$46K Buy
+2,175
New +$47.9K ﹤0.01% 3335

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BlackRock Advisors's NEOS Position: Q4 2016 in Review

BlackRock Advisors held its Neos Therapeutics, Inc (NEOS) position steady in Q4 2016 at 3,896 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #3433.

BlackRock Advisors first reported a position in NEOS in Q3 2015 and has held it in 6 quarters since. The position peaked at $46K in Q3 2015. 52 funds tracked by Wall St. Rank hold NEOS as of Q4 2016.

  • BlackRock Advisors held 3,896 shares of Neos Therapeutics, Inc worth $23K as of Q4 2016.
  • BlackRock Advisors left its Neos Therapeutics, Inc share count unchanged in Q4 2016.
  • Neos Therapeutics, Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3433 holding.
  • BlackRock Advisors first reported a position in Neos Therapeutics, Inc in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Advisors's Neos Therapeutics, Inc position peaked at $46K in Q3 2015.
  • 52 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.